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Abstract 
Methods:  In this cross sectional study two 
hundred-thirty six diabetic patients (126 males and 
110 females) participated. Patients included in the 
study were newly diagnosed as diabetic according to 
WHO criteria. Dyslipidemia was defined by 
presence of one or more than one abnormal serum 
lipid concentration, according to National Cholestrol 
Education Program Adult Treatment Panel III (NCEP 
ATP III) guideline. Weight was measured using 
electronic digital scales. Height was measured using 
a wall-mounted stadiometer. BMI was subsequently 
calculated as weight (kg) per height (m2). Fasting 
plasma glucose and 2h-BG (after 75 g glucose load) 
were estimated for all studied subjects. Three ml of 
blood was collected in EDTA bottles for 
measurement of HBA1c by immunoturbimetry 
method.  Statistical analysis was performed using t-
test. Significance was defined as p˂0.05. 
Results: Of the 236 patients, 126 patients were male 
and 110 were female ranging from the age group 35-
80 years. The mean BMI 24.3, Total Cholesterol 163.9 
mg/dl, TGL 126.8mg/dl, HDL 29.9 mg/dl, VLDL 31.6 
mg/dl, LDL 108.7 mg/dl was seen in patients having 
HbA1c of less than 6.5. The mean HbA1c 6.7%, Total 
Cholesterol 160.3 mg/dl, TGL 146, HDL 27.3 mg/dl, 
VLDL 37.6 mg/dl, LDL 101 mg/dl was seen in 
patients having BMI of less than 25. 
Conclusion: There is a direct association of high 
BMI, elevated HbA1c and deranged lipid profiles in 
patients of diabetes mellitus. HbA1c and BMI 
showed positive correlation with lipid profile 
including total Cholesterol, LDL, TGL, VLDL & 
negative correlation was found with HDL levels.   
Key Words: Diabetes mellitus, Glycosylated 
haemoglobin, Body Mass Index 
Introduction 
In both developed and developing countries diabetes 
increasing prevalence of Diabetes Mellitus  (DM) is 
becoming a global endemic. Worldwide DM is one of 
the leading causes of death. In Pakistan the prevalence 
of type 2 diabetes mellitus is now reaching about 
11.77%. 1,2  Globally the prevalence of DM  was about 
8% in 2011. Its prevalence is expected to increase to 
10% by 2030.3 Low- and middle-income countries 
comprise of about 80% of patients with DM.  
Particularly affected areas are Asia and Pacific.4 
Currently prevalence of DM is 11.7% in Pakistan.5 
Type-2 DM is commonly associated with obesity, 
ethnicity, sedentary lifestyles, sex,family history, 
hypertension, smoking and alcohol consumption.6 
However there is now overwhelming evidence from 
experimental, epidemiological and intervention 
studies shows that obesity is one of the major risk 
factor leading to DM among all risk factors. 
According to WHO criteria Obesity is defined as a 
Body Mass Index (BMI) of >30 kg/m2. Being obese is a 
significant public health problem across the world, 
affecting almost an estimated of one billion people. 
This leads to complications like hypertension, DM, 
cardiovascular disease  and death7. Worsening of 
glycemic control deteriorates lipid and  lipoprotein 
abnormalities in DM.8 American Association of 
Clinical Endocrinologists recommend glycosylated 
hemoglobin(HbA1c) level of less than 6.6%. Elevated 
levels of Triglyceride (TG),Total Cholesterol 
(TC)&Low Density Lipoproteins (LDL) are 
documented as risk factors of atherogenesis. 7 In Type-
2  DM, lipid abnormalities are almost always present. 
70 to 97% of adults with Type-2 DM have one or more 
lipid abnormalities.8-9 The pattern of lipid profile in 
Type-2 DM is called diabetic dyslipidemia or 
atherogenic dyslipidemia comprising of raised 
triglycerides, reduced High Density Lipoproteins 
(HDL), and excess small dense LDL particles. Index of 
diabetes is provided by glycated haemoglobin 
(HbA1c).An average of blood glucose levels in a 
patient during the past 2–3 months is the most 
objective and reliable measure for long-term metabolic 
control of glucose.11 
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Patients  and Methods  
This cross sectional study was  conducted in Pathology 
Department of Pakistan Institute of Medical Sciences, 
Islamabad, from April to October 2017. Sample size 
came out to be 236 using Confidence Level 95%, 
Confidence Interval 5% and reference population 610. 
Two hundred-thirty six diabetic patients (126 males 
and 110 females) participated in this study and their 
ages ranged between 35 and 85 years. Non probability 
convenient sampling was done. Patients included in 
the study were diagnosed as diabetic according to 
WHO criteria which is “An HbA1c of 6.5% is 
recommended as the cut point for diagnosing diabetes. 
A value of less than 6.5% does not exclude diabetes 
diagnosed using glucose tests.” All patients were 
newly diagnosed or known cases of type 2 DM. 
Patients with abnormal liver function, nephropathy, 
neuropathy or retinopathy and patients not giving  
consent were excluded from the study. Dyslipidemia 
was defined by prescence of one or more than one 
abnormal serum lipid concentration, according to 
National Cholestrol Education Program Adult 
Treatment Panel III (NCEP ATP III) guideline. 
Diabetes was defined as per World Health 
Organization (WHO) criteria. Weight was measured 
using electronic digital scales. Height was measured 
using a wall-mounted stadiometer. BMI was 
subsequently calculated as weight (kg) per height 
(m2). Five ml of venous blood was collected into plain 
vacutainers after 8 hours of fasting, and then 
centrifuged so that serum was separated. The sera 
were used to measure lipid profile using 
spectrophotometric methods. Fasting plasma glucose 
and 2h-BG (after 75 g glucose load) were estimated for 
all studied subjects. 3ml of blood was collected in 
EDTA bottles for measurement of HBA1c by 
immunoturbimetry method.  Significance was defined 
as p˂0.05. 
 
Results 
Of the 236 patients, 126 patients were male and 110 
were female ranging from the age group 35-80 years. 
Hypercholesterolemia is defined as TC >200 mg/dl, 
High LDL when value is >100 mg/dl, 
Hypertriglyceridemia as TAG >150mg/dl, & low HDL 
when value <40 mg/dl. The mean BMI 24.3, Total 
Cholesterol 163.9 mg/dl, TGL 126.8, HDL 29.9 mg/dl, 
VLDL 31.6 mg/dl, LDL 108.7 mg/dl was seen in 
patients having HbA1c of less than 6.5 (Table 
1).Patients with good glycemic controls had HDL 
values lower than the normal.The mean BMI 28, Total 
Cholesterol 219.0 mg/dl, TGL232.5 mg/dl, HDL 37.3 
mg/dl, VLDL 39 mg/dl, LDL 134 mg/dl was seen in 
patients having Hba1c of more than 6.5. By comparing 
both the groups it was found that though the lipid 
parameters were elevated in patients having 
uncontrolled glycemic status(HbA1c >6.5), all these 
parameters were positively and significantly elevated 
except HDL which was found to be decreased in 
patients having uncontrolled glycaemic 
status(HbA1c>6.5). The mean HbA1c 6.7%, Total 
Cholesterol 160.3 mg/dl, TGL 146, HDL 27.3 mg/dl, 
VLDL 37.6 mg/dl, LDL 101 mg/dl was seen in 
patients having BMI of less than 25. The HDL levels 
were also lower in the normal BMI range. 
 
Table 1: Mean levels of lipid profile and  BMI 
based on HbA1c in type 2 diabetic patients 
HbA1c BMI Lipid profile  (mg/dl) 
Total 
Cholesterol  
Triglyc
erides  
HDL VLDL LDL 
<6.5 24.3 163.9 126.8 29.9 31.6 108.7 
>6.5 28 219 232.5 37.3 39 134 
 0.001  0.002  0.013   0.192  0.018 0.030 
SIG HS HS HS NS HS HS 
Table 2: Mean levels of lipid profile and HbA1c 
based on BMI in type 2 diabetic patients 
 
 
      
BMI 
 
     
HbA1c 
Lipid Profile (mg/dl) 
Total 
Cholesterol 
TGL HDL VLDL LDL 
<25 6.7 160.3 146 27.3 37.6 101 
>25 8.7 220.9 240 35.1 38.8 146.3 
 0.003  0.001  0.009   0.220  0.020 0.001 
SIG HS HS HS NS HS HS 
 
The mean HbA1c 8.7 %, total cholesterol 220.9 mg/dl, 
TGL240 mg/dl, HDL35.1 mg/dl, VLDL 38.8 mg/dl, 
LDL 146.3mg/dl was seen in patients having BMI of 
more than 25.By comparing both the groups it is found 
that though the HbA1c and all the other lipid 
parameters were elevated in patients having BMI of 
more than 25, all these parameters were positively and 
significantly elevated except HDL which was found to 
be decreased in patients having BMI of more than 25 
(Table 2) 
Discussion 
The present study associates lipid profile parameters, 
HbA1c and BMI parameters in Diabetic patients and 
their correlation. The levels of HbA1c amd lipid profile 
parameters didn’t differ significantly between male 
and female. The present study has shown 
dyslipidemia with significant rise in total cholesterol, 
TGL, LDL in patients who had BMI >25. Both Lipid 
profile and BMI have been shown to be the important 
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predictors for metabolic disturbances. Obesity 
predisposes the individuals to DM. While 
dyslipidemia has association with both Obesity and 
Diabetes Mellitus.12-13 It was also found that though 
the lipid parameters were elevated in patients having 
uncontrolled glycaemic status(Hba1c >6.5) , all these 
parameters were positively and significantly elevated 
except HDL which was found to be decreased in 
patients having uncontrolled glycaemic status(HbA1c 
>6.5).  
HDL levels are deranged in good glycaemic control 
group (HbA1c <6.5%) as well as in normal BMI range 
(< 25Kg/m2). As evident from other studies HDL 
levels are lower in South Asian population.14 Similar 
findings have been observed in our study. 
A positive association was seen between HbA1c and 
dyslipidaemia, it has been reported that severity of a 
increases among patients at higher levels of HbA1c.15 
High BMI, elevated Hba1c and Dyslipidemia have 
direct association with diabetes mellitus.16-17 So when 
managing the patients of diabetes it is important to 
consider all three of these parameters. Dietary 
modifications, lifestyle changes, regular exercise and 
proper medication are necessary along with proper 
work up of lipid profile, BMI and HbA1c in patients to 
prevent complications of type 2 DM. 
 
Conclusion 
1. There is direct association of High BMI, 
elevated HbA1c and dyslipidemia among the 
patients of type 2 diabetes mellitus. No significant 
difference between genders in glycemic status or 
lipid profile was found. HbA1c and BMI showed 
positive correlation with lipid profile including 
Total Cholesterol, LDL, TGL, VLDL and negative 
correlation was found with HDL levels.   
2. HDL levels were lower at HbA1c < 6.5% and 
BMI < 25%. These findings suggest that for proper 
management for the patients of  Type-2 DM all 
three of these parameters should be given 
importance and treated accordingly to prevent 
complications of type 2 diabetes mellitus. 
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